Neudle.com: recombinant activated factor VII

Differential
(Click to cross reference)

Showing articles 650 to 700 of 4059 << Previous Next >>

Direct Endovascular Thrombolytic Therapy for Dural Sinus Thrombosis:Infusion of Alteplase
AJNR 18:639-645, Kim,S.Y.&Suh,J.H., 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997

Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997

A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
NINDS Stroke Study Group, Stroke 28:1530-15401997., , 1997

When is Thrombolysis Justified in Patients with Acute Stroke? A Bioethical Perspective
Stroke 28:214-218, Furlan,A.J.&Kanoti,G., 1997

Tissue-Type Plasminogen Activator Should Not be Used in Acute Ischemic Stroke
Arch Neurol 53:1306-1308, Riggs,J.E., 1996

Thrombolysis for Stroke
Arch Neurol 53:1305-1306, 13081996., Brott,T., 1996

TPA Within 3 Hours of Acute Ischaemic Stroke
Lancet 348:1600-1601, Dorman,P.&Sandercock,P., 1996

Startle Provoked Epileptic Seizures:Features in 19 Patients
JNNP 61:151-156, Manford,M.R.A.,et al, 1996

Good Clinical Outcome in a Pt with Large CT Scan Hypodensity Treated with Intra-Arterial Urokinase after Embolic Stroke
Neurol 47:1076-1078, Tarr,R.,et al, 1996

Streptokinase for Acute Ischemic Stroke with Relationship to Time of Administration
JAMA 276:961-966, 9951996., Donnan,G.A.,et al, 1996

Reduced Response to Activated Protein C is Associated with Increased Risk for Cerebrovascular Disease
Ann Int Med 125:265-269, van der Bom,J.G.,et al, 1996

Cerebral Venous Sinus Thrombosis Associated with Factor V Gene Mutation
JNNP 61:204-205, Kimber,T.,et al, 1996

Open Trial of I. V. Tissue Plasminogen Activator in Acute Carotid Territory Stroke-Correl of Outcome with Clin & Radiol Data
Stroke 27:882-890, Trouillas,P.,et al, 1996

Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
The MAST-E Study Group, NEJM 335:145-1501996., , 1996

Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996

Thrombolysis in Acute Stroke, Defining Risk to Benefit Ratio
BMJ 313:640-641, Bogousslavsky,J., 1996

Cerebral Venous Thrombosis:Role of Activated Protein C Resistance and Factor V Gene Mutation
Stroke 27:1719-1720, Brey,R.L.&Coull,B.M., 1996

Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996

Status Epilepticus in Children with Epilepsy:The Role of Antiepileptic Drug Levels in Prevention
Pediatrics 98:1119-1121, Maytal,J.,et al, 1996

Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996

Hemorrhagic Transfor of Brain Infarct:Predictability in First 5 hrs. From Stroke Onset & Influ on Clin Outcome
Neurol 46:341-345, Toni,D.,et al, 1996

Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996

Intra-Arterial Thrombolysis in Acute Ischaemic Stroke:Experience with a Superselective Catheter Embedded in the Clot
JNNP 60:667-670, Castro,L.,et al, 1996

Thrombolytic Therapy of Acute Basilar Artery Occlusion-Variables Affecting Recanalization and Outcome
Stroke 27:875-881, Brandt,T.,et al, 1996

Thrombolytic Therapy in Acute Occlusion of the Intracranial Internal Carotid Artery Bifurcation
AJNR 16:1977-1986, 19941995., Jansen,O.,et al, 1995

Cost-effectiveness of Emergency Intraarterial Intracerebral Thrombolysis:A Pilot Study
AJNR 16:1987-1993, 19941995., Lanzieri,C.F.,et al, 1995

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke:The ECASS
JAMA 274:1017-1025, 10581995., Hacke,W.,et al, 1995

Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995

Randomised Contr Trial of Streptokinase
Aspirin & Comb in Trtm of Acute Ischaemic Stroke, Multictr Acute Stroke Trial-Italy, Lancet 346:1509, 15145,1504,1995., 1995

Does Arterial Recanalization Improve Outcome in Carotid Territory Stroke?
Stroke 26:581-587, vonKummer,R.,et al, 1995

Intraventricular Recombinant Tissue Plasminogen Acivator for Lysis of Intraventricular Haemorrhage
JNNP 58:447-451, Rohde,V.,et al, 1995

Treatment of Dural Sinus Thrombosis Using Selective Catheterization and Urokinase
Ann Neurol 38:58-67, Horowitz,M.,et al, 1995

Ischemic Stroke in Young Pts with Activated Protein C Resistance:Rpt of Three Cases Belonging to Three Different Kindreds
Stroke 26:885-890, Simioni,P.,et al, 1995

Reading-Induced Absence Seizures
Neurol 45:1623-1624, Singh,B.,et al, 1995

First Seizures Associated with Playing Electronic Screen Games:A Community-Based Study in Great Britain
Ann Neurol 37:733-737, Quirk,J.A.,et al, 1995

Dural Sinus Thrombosis Complicating Subclavian Vein Catheterization:Treatment with Local Thrombolysis
Pediatrics 95:138-140, Gebara,B.M.,et al, 1995

Thrombolysis and Low Back Pain
BMJ 310:504, Fishwick,D.,et al, 1995

Thrombolytic Treatment for Acute Occlusion of the Basilar Artery
JNNP 58:227-228, Huemer,M.,et al, 1995

Embolic Stroke Following Thrombolytic Therapy for Myocardial Infarction in a Patient with Preexisting Ventricular Thrombi
Stroke 26:324-325, Bautista,R.E.D., 1995

Hirudin in Acute Myocardial Infarction
Circulation 90:1624-1630, 1631, 2147994., Antman,E.M., 1994

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994